Treatment Options for Pediatric Leukemia

Treatment Options for Pediatric Leukemia Leukemia is the most prominent cancer affecting children and teens with treatment options still being researched. Stem cell therapy has emerged as a potential treatment option in addition to chemotherapy. This literature analysis explores two specific treatments for pediatric patients diagnosed with leukemia to examine how it impacts the improvement of patient outcomes. By reviewing existing research from 2019 to 2024, the analysis reveals that the combination of stem cell therapy with chemotherapy leverages the effects of both treatments. The combined approach of stem cell therapy and chemotherapy has been proven to improve remission rates and the overall survival of patients compared to chemotherapy alone. With this treatment, the chemotherapy destroys both healthy and cancer cells, while the stem cells restore the damaged cells. By incorporating stem cell therapy with chemotherapy, the number of healthy cells is increased, which enables higher doses of chemotherapy to be administered. This approach results in improved outcomes and reduces the adverse effects associated with the insufficiency of healthy cells. Despite the possible complications, these findings underscore the importance of integrating both therapies to strengthen treatment outcomes, while minimizing adverse effects and striving for safer interventions in the treatment of pediatric leukemia. Keywords: pediatric leukemia, chemotherapy, stem cell therapy, literature analysis, cancer